臺灣博碩士論文加值系統

氧化氮 (Nitric oxide；NO) 普遍存在於我們周圍的環境中，為一個具有生理功能的活躍分子；而其雖具有許多生物功能，但相同的亦會引發一些疾病。伴隨著Furchgott、Ignarro和Murad榮獲1998年諾貝爾醫學獎的旋風， NO所擁有之獨特性質再次受到世人的注目。延續這股熱潮，本研究亦想了解其對於路易士肺癌細胞 ﹝Lewis lung carcinoma (LLC) cells ﹞ 之細胞-遺傳上的毒性。我們以路易士肺癌細胞 (LLC) 標本為主，中國頰鼠肺細胞 ﹝V79 Chinese hamster lung (V79) cells﹞ 為對照細胞，分別加入氧化氮供給劑 (NO dornors)：sodium nitroprusside (SNP)、3- morpholinosydnonimine (SIN-1)、S-nitrosoglutathione (GSNO)和S-nitroso-N-acetyl—DL-penicillamine (SNAP) 和抗癌藥物adriamycin (ADM) 後，再利用微小核法觀察其遺傳毒性、以MTT分析法評估其細胞毒性、以流式細胞儀分析法偵測其對細胞週期的改變與細胞凋亡之情形以及利用CPP32分析法來更進一步確認這些藥物與細胞凋亡的關聯性。另一方面，也以MTT分析法來觀測鈣離子抑制劑verapamil (VPM) 加強SNP或ADM作用之情形，藉此我們希望可以提供更具前瞻性的化學療法。實驗結果發現：
(1).在LLC細胞中，四種100mM NO供給劑或0.3mM ADM均會呈現時間相關性地增加MN (Micronuclei) 出現的頻率，降低細胞存活率和NDI (Nuclear division index) 值。
(2).對V79細胞而言，100mM SNP或0.3mM ADM均會呈現時間相關性地增加MN出現的頻率，降低細胞存活率和NDI值。此外，SNP和ADM在V79細胞之遺傳毒性均大於在LLC細胞。
(3).四種NO供給劑呈濃度相關性地降低LLC細胞之細胞存活率。四種NO供給劑以SNP (ED50：100mM) 之細胞毒性最強，但遠不及ADM。
(4).在LLC細胞中，100mM SNP會加強0.3mM ADM的細胞毒性；相同地，30mM和100mM VPM會加強0.3mM ADM之細胞毒性。
(5).在V79細胞中，30mM和100mM SNP會加強0.3mM ADM之細胞毒性。
(6).在分析細胞凋亡指標方面，我們發現四種NO供給劑於100mM的濃度時，無論是在LLC細胞或是V79細胞均不會出現sub-G1 細胞，顯示其在LLC細胞或V79細胞均不引發細胞凋亡。此外四種NO供給劑在LLC細胞在存在下會減少其細胞體積，但增加其細胞顆粒度。
(7).相對地，0.3mM ADM不僅會引發LLC細胞的凋亡，而且會造成LLC細胞和V79細胞大量累積在G2/M phase。
(8).CPP32活性分析法結果顯示只有0.3mM ADM 均會經由活化CPP32活性而造成細胞凋亡。
總而言之，在我們的研究中發現：四種100mM NO供給劑或0.3mM ADM在V79細胞和LLC細胞均會增加MN的頻率，降低細胞存活率和NDI值；但在光學顯微鏡下並不會顯著改變LLC和V79細胞之型態。由於四種 NO供給劑必須相當高的濃度下 (ED50：100mM - 1mM) 才會對LLC細胞有細胞的毒性，因此在臨床上100mM NO供給劑並不適合當抗癌藥。另一方面，對LLC細胞而言100mM SNP能加強0.3mM ADM對LLC細胞之毒殺性；但對V79細胞而言30mM SNP便可加強0.3mM ADM對V79細胞之毒性，顯示SNP不適合和0.3mM ADM聯合使用。VPM ³ 30mM亦可加強ADM在LLC細胞之細胞毒性，但因未做V79細胞之對照實驗，所以其相關性尚待證實。而實驗中亦顯示0.3mM ADM 會經由活化CPP32活性引發細胞的凋亡，而四種100mM之NO供給劑似乎與此途徑沒有關聯。最後，由於0.3mM ADM無論在LLC細胞或V79細胞之細胞凋亡和微小核數據無法相互佐證，所以初步推論微小核之形成和細胞凋亡並無相關性。因此對於尋求更具潛力的化學療法而言，無疑地仍待我們努力做進一步的探討。

Nitric oxide (NO) is a ubiquitous, physiologically active molecule involved in many biological functions and diseases. The unique attributes and importance of NO were recently recognized by the Nobel Prize Committee, with their decision to award the 1998 Prize in Medicine to Drs. Furchgott, Ignarro, and Murad. In this study, we attempted to investigate the genotoxic and cytotoxic effects of different nitric oxide donors, sodium nitroprusside (SNP), 3-morpholinosydnonimine (SIN-1), S-nitroso -glutathione (GSNO), and S-nitroso-N-acetyl-DL -penicillamine (SNAP), and anticancer drug, adriamycin (ADM), respectively, both in Lewis lung carcinoma (LLC) cells and V79 Chinese hamster lung (V79) cells. We used micronucleus assay to evaluate the genotoxic effects, MTT assay to evaluate the cytotoxic effects, flow cytometry to evaluate cell cycle and apoptosis, and also used assay the CPP32 activity to confirm apoptosis. In addition, we also used MTT assay to evaluate the effect of Ca2+-channel blocker (verapamil；VPM) on SNP, or ADM-induced cytotoxicity in LLC cells, we hope the results will afford useful references to improve the potency of cancer chemotherapy. We demonstrated that: (1). All of four 100 mM NO donors or 0.3 mM ADM significantly increased MN (Micronuclei) frequency, but decreased both cell viability and NDI (Nuclear division index) in a time-dependent manner in LLC cells. (2). 100 mM SNP or 0.3 mM ADM also significantly increased MN frequency, and decreased both cell viability and NDI in a time-dependent manner in V79 cells. However, both SNP and ADM-induced more genotoxicity in V79 cells than in LLC cells. (3). All of four NO donors significantly decreased cell viability in a concentration-dependent manner in LLC cells. SNP appears the best cytotoxic effect (ED50 : 100 mM) among the four NO donors but markedly weaker than 0.3 mM ADM. (4). In this study, 100 mM SNP potentiated ADM-induced cytotoxicity, 30 mM and 100 mM VPM also increased ADM-induced cytotoxicity in LLC cells, respectively. (5). 30 mM and 100 mM SNP also increased 0.3 mM ADM-induced cytotoxicity in V79 cells (6). The data of hyperploids showed that all of 100mM NO donors neither induced sub-G1 cells in LLC nor in V79 cells, the results point out all of 100 mM NO donors didn’t induced apoptosis in both LLC and V79 cells. However, the four NO donors decreased cellular size and increased cellular granules in LLC cells. (7). By contrast, 0.3 mM ADM induced apoptosis in LLC cells and induced G2/M phase block in both LLC cells and V79 cells. (8). The results of CPP32 assay showed that only 0.3 mM ADM increased the activity of CPP32 in LLC cells.
In conclusion, the results indicated that all of four 100 mM NO donors and 0.3 mM ADM significantly increased MN frequency, and decreased cell viability and NDI both in LLC and V79 cells. However, they did not markedly change cell morphology of both LLC and V79 cells. Because all of four NO donors induced cytogenotoxic effects must in high concentrations in both LLC and V79 cells, so we supposed 100 mM NO donors could unsuitably be anticancer drugs in clinical therapeutics. On the other hand, 100 mM SNP increased 0.3 mM ADM-induced cytoxicity in LLC cells. However, SNP at lower concentration (30 mM) potentiated ADM-induced cytoxicity in V79 cells. Obviously, SNP can not combine with 0.3 mM ADM to treat cancer. VPM ³30 mM also increased ADM-induced cytotoxicity in LLC cells, but the value of potentially cytotoxic effect of VPM with ADM must do further study in V79 cells. In addition 0.3 mM ADM induced apoptosis via induced the CPP32 activity in LLC cells, but not NO donors. At last, the data of ADM-induced MN didn’t correlate with the data of ADM-induced apoptosis in both LLC cells and V79 cells; the results suggest that there is no relationship between apoptosis and MN. In this study, we afforded rarely new information in providing the better chemotherapy in cancer. Obviously, we have to design a further plan about this study.

中文摘要 (Chinese abstract) ---------- 1
英文摘要 (English abstract) ---------- 4
緒論 (Introduction) ------------------ 8
材料與方法 (Materials & Methods) ---- 25
結果 (Results) ---------------------- 41
討論 (Discussion) ------------------- 55
圖表 (Figures & Tables) ------------- 65
附錄 (Appendix) --------------------- 94
1.細胞凋亡 (Apoptosis) ------------- 94
2.p53蛋白 (p53 protein) ------------ 96
3.流式細胞分析法 (Flow cytometry) -- 97
4.微小核法 (Micronucleus assay)---- 101
5.MTT assay------------------------ 101
參考文獻 (References)--------------- 102

Adams, D.O. (1979): Macrophages Method. Enzymol. LVIII : 494 — 506.
Amara-Mokrane, Y.A., Lehucher-Michel, M.P., Balansard, G., Dumenil, G. and Botta, A. (1996)：Protective effects of alpha-hederin, chlorophllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagen. 11：161-167.
Anilkumar, T.V., Sarraf, C.E., Hunt, T. and Alison, M.R. (1992)：The nature of cytotoxic drug-induced cell death in murine intestinal crypt. Br. J. Cancer 65：552-558.
Anwyl, R. (1989): Protein kinase C and long-term potentiation in the hippocampus. Trends Pharmocol. Sci. 10:236-239.
Arnold, W.P., Mittal, C., Katsuki, S. and Murad, F. (1977)：Nitric oxide activation guanylate cyclase and increases guanosine-3’-5’-monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U.S.A. 74：3203-3207.
Arroyo, P. L., Pigott, V.H., Mower, H.F. and Cooney, R.V. (1992)：Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. 281：193-202.
Azmi, S., Bhatia, L., Khanna, N., Dhawan, D. and Singh, N. (1997)：Adriamycin induces apoptosis in rat thymocytes. Cancer Lett. 111：225-231.
Barry, M.A., Behnke, C.A. and Eastman, A. (1990)：Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40：2353-2362.
Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. (1990)：Apparent hydroxyl radical production by peroxynitrite：implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87：1620-1624.
Blanco, F.J., Ochs, R.L., Schwarz, H. and Lotz, M. (1995)：Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146：75-85.
Bredt, D.S. and Snyder, S.H. (1989)：Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86：9030-9033.
Brockhaus, F. and Brune, B. (1999)：p53 accumulation in apoptosis macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene 18：6403-6410.
Brune, B., von Knethen, A. and Sandau, K.B. (1999)：Nitric oxide (NO)：an effector of apoptosis. Cell Death Differenti. 6：969-975
Burney, S., Tmir, S., Gal, A. and Tannenbaum, S.R. (1997)：A mechanistic analysis of nitric oxide-induced cellular toxicity. Nitric Oxide Biol. Chem. 1：130-144.
Chin, L.S., Park, C.C., Zitnay, K.M., Sinha, M., Dipartri, A.J. Jr., Perillu, P. and Simard, J.M. (1997)：4-Aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines. J. Neurosci. Res. 48：122-127.
Cohen, C. (1977)：Protein assemblies and cell form. Biol. Chem. Sci. 2：51.
Cohen, G.M. (1997)：Caspases：the executioners of apoptosis. Biochem. J. 326：1-16.
Dimanche-Boitrel, M.T., Genne, P., Duchamp, O. and Chauffert, B. (1994)：Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer. Leet. 85：171-176.
Durner, J. and Klessig, D.F. (1999)：Nitric oxide as a signal in plants. Curr. Opin. plant Biol.
Eastmond, D.A. and Tucker, J.D. (1989): Identification of aneuploidy-inducing agents using cytokinesis blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutag. 13:34-43.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A. and Nagata, S. (1998)：A caspase-activatated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391：43-50.
Feehlisch, M., Ostrowski, J. and Noack, E. (1989)：On the mechanism of NO release from sydnomines. J. Cardiovas. Pharmacol. 14 (suppl. 11)：S13-S22.
Fenech, M. and Morley, A.A. (1985): Measurement of micronuclei in lymphocytes. Mutat. Ress. 147: 29 — 36.
Forrester, K., Amb, S., Lupold, S.E., Kapust, R.B., Spillare, E.A., Weinberg, W.C., Felley-Bosco, E., Wang, X.W., Geller, D.A., Tzeng, E., Billiar, T.R. and Harris, C.C. (1996)：Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Nat1. Acad. Sci. USA 93：2442-2447.
Furchgott, R.F. and Zawadazki, J.V. (1980)：The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288：373-376.
Gal, A. and Wogan, G.N. (1996)：Mutagenesis associated with nitric oxide production in transgenic SJL mice. Proc. Natl. Acad. Sci. U.S.A. 93：15102-15107.
Gerschenson, L.E. and Rotello, R.J. (1992)：Apoptosis：a different type of cell death. FASEB J. 6：2450-2455.
Gobbel, G.T., Chan, T.Y. and Chan, P.H. (1997)：Nitric oxide and superoxide mediated toxicity in cerebral endothelial cells. J. Pharmacol. Exp. Ther. 282：1600-1607.
Gottesman, M.M. and Pastan, I. (1993)：Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62：385-427.
Green, L.C., Wagner, D.A., deLuzuriaga, R.K., Istfan, N., Young, V.R. and Tannenbaum, S.R. (1981)：Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. U.S.A. 78：7764-7768.
Gurr, J.R., Liu, F., Lynn, S. and Jan, K.Y. (1998)：Calcium-dependent nitric oxide production is involved in aresenite-induced micronuclei. Mutat. Res. 416：137-148.
Haijar, D., Lander, H.M., Prearce, S.F., Upmacis, R.K., Pomerantz, K.B. (1995): Nitric oxide enhances prostaglandin-H synthase activity by a heme-independent mechanism: evidence implicating nitrosothiols. J. Am. Chem. Soc. 117: 3340-3346.
Han, M-F., Her, Q-Y., Ohnishi, A., Yamamoto, T., Hashiguchi, H. and Murai, Y. (1998)：Nuclear pore changes and absence of apoptosis in lumbar dorsal root ganglion neurons of doxorubicin-intoxicated rats. J.Uoeh 20：115-125.
Heddle, J.A. and Carrano, A.V..(1973): The DNA content of micronuclei induced in mouse bone marrow by gamma-irradiation: evidence that micronuclei arise from acentric chromosomal fragments. Mutat. Res. 44:63-69.
Hibbs, J.B., J.R., Taintor, R.R., Vavrin, Z. (1987)：Macrophage cytotoxicity：role for L-arginine deaminase and iminuo nitrogen oxidation to nitrite. Science 235：473-476.
Ignarro, L.J., Degnan, J.N., Baricos, W.h., Kadowitz, P.J. and Wolin, M.S. (1982)：Activation of purified guanylate cyclase by nitric oxide requires heme：comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochem. Biophy. Acta. 718：49-59.
John, C.Z., Teresa, L.W., Teresa, D.W., Steven, R.T. and Gerald, N.W. (2000)：Nitric Oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environ. Mol. Mutagen. 35：39-47.
Kanani, P.M., Sinkey, C.A., Browning, R.L., Allaman, M., Knapp, H.R. and Haynes, W.G. (1999)：Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Cir. 100：1161-1168.
Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstin, B. and Craig, R.W. (1991)：Participation of p53 protein in the cellular response to DNA damage. Cancer. Res. 51：6304-6311.
Kerr, J.F.R. (1965)：A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J. Pathol. Bacteriol. 90：419-435.
Kerr, J.F.R. and Searle, J. (1972)：A suggested explanation for the paradoxically slow growth rate of basal cell carcinomas that contain numerous mitotic figure. J. Pathol. 107：41-44.
Kerr, J.F.R., Wyllie, A.H. and Currie, A.R., ( 1972)：Apoptosis：a basic biologic phenomenon with wild-ranging implications in tissue jinetices. Br. J. Cancer 26：239-257.
Konopa, J. (1988)：G2 block induced by DNA crosslinking agents and its possible consequence. Biochem. Pharmaclo. 37：2303-2309.
Kowaluk, E.A., Seth, P. and Fung, H.L. (1992)：Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. pharmcol. Exp. Ther. 262：916-922.
Kroncke, K.D., Fehsel, K. and Victoria, K.B. (1997)：Nitric oxide：cytotoxicity versus cytoprotection-how, why, when, and where？Nitric oxide Bio.chem. 1：107-120
Lander, H.M., Ogiste, J.S., Pearce, S.F., Levi, R., Novogrodsky, A. (1995): Nitric oxide-stimulated guanine nucleotide exchange on p21 ras. J. Biol. Chem. 270: 7017 — 7020.
Lee, P.C. and Lin, R.H. (1999)：Studies on the cytogenotoxicities of semiconductor metals, copper nitrate, manganese nitrate, nickel nitrate and lead nitrate, in V79 Chinese hamster lung cells. (Master thesis, Institute of Medicine, Chung Shan Medical and Dental College)
Leung, L.K. and Wang, T.T.Y. (1999)：Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Cancer Res. Tre. 55：73-83.
Lin, W., Xue, H., Liu, S., He, Y., Fu, J. and Zhou, Z. (1998)：Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutat. Res. 413：121-127.
Ling, Y.-H. El-Naggar, A.K., Priebe, W. and Perez-Soler, R. (1996)：Cell cycle-dependent cytotoxicity, G2 / M phase arrest, and disruption of p34 (cdc2) / cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol. Pharmacol. 49：832-841.
Lipton, S.A., Choi, Y.B., Pan, Z.H., Lei, S.Z., Chen, H.S.V., Sucher, N.J., Loscalzo, J., Singel, D.J., Stamler, J.A. (1993): A redox-based mechanism for the neuroprotective and neurodestructive effects of nitrics of nitric oxide and related nitroso-compounds. Nature 364: 626 — 632.
Lohmann, S.M., Fischmeister, R. and Walter, U. (1991)：Signal transduction by cGMP in the heart. Basic Res. Cardiol. 86：503-514.
Marnett, L.J., and Burcham, P.C. (1993): endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol. 6: 771 —785.
Me bmer, U.K., Reimer, D.M. and Brune, B. (1998)：Protease activation during nitric oxide-induced apoptosis：comparison between poly (ADP-ribose) polymerase and U1-70kDa cleavage. Eur. J. Pharmacol. 349：333-343.
Messmer, U.K. and Brune, B. (1995)：Nitric oxide-induced apoptosis：p53-dependent and p53-independent signaling pathways. J. Biochem. 319：299-305.
Miwa, M., Stuhr, D.J., Marletta, M.A., Wishnok, J.S. and Tannenbaum, S.R. (1987)：Nitrosation of amines by stimulated macrophages. Carcinogenesis 8: 955 — 958.
Moncada, S., Palmer, R.M.J. and Higgs, A.E. (1991)：Nitric oxide：physiology, pathophsiology and pharmacology. Pharmacol. Rev. 43：109-141.
Moro, M., Paz, F.T., Leza, J.C., Lorenzo, P. and Lizasoain, I. (1998)：Neuronal death induced by SIN-1 in the presence of superoxide dismutase：protection by cyclic GMP. Neuropharmacol. 37：1071-1079.
Mosmann, T. (1983): Rapid colorimetric assay for cellular growth and survival: application and cytotoxicity. J. Immunol. Methods 65:55.
Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S. and Tannenbaum, S.R. (1992)：DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89：3030-3034.
Niels, H.B., Ulf, S., Hans, K.P. and Michael, J.M. (2000)：Nitric oxide, prostanoid and non-NO, non- prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br. J. Pharmacol. 129：184-192.
Pae, H.O., Yoo, J.C., Choi, B.M., Kang, C.L., Kim, J.D. and Chung, H.T. (1999)：Apoptosis cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells. Immunopharmacol. & Immunotoxicol. 21：667-682.
Palmer, R.M.J., Ferrdige, A.G. and Moncada, S. (1987)：Nitric oxide releases accounts for the biological activity of endothelium-derived relaxing factor. Nature 327：524-526.
Painter, R.B. and Young, B.R. (1980): Radiosensitivity in ataxia telangiectaxia: a new explanation. Proc Natl Acad Sci U.S.A. 77:7315-7317.
Phoon, L.Y., Liao, P.H., Lin, R.H. and Shiau, S.Y. (1999)：Effects of cationic channel blockers on adriamycin-induced cytotoxicity in Lewis lung carcinoma cells.
Potmesil, M. (1988)：DNA topoisomerase II as intracellular target in anthracycline treatment of cancer. In：anthracenedione-based anticancer agents (Ed. Lown J.W.), PP.447-466. Elservier Science, Amsterdam.
Powis, G. (1987)：Anthracycline metabolism and free raical formation. In：Metabolism and action of anti-cancer drugs (Eds. Powis G. and Prough R.A), PP.211-260. Taylor and Francis, Landon
Pu, T.S., Hsieh, T.S., Tasi, T.C., Cheng, A.L., Hsieh, C.Y., Su, I.J. and Lai, M.K. (1995)：Tamoxifen enhances the chemosensitivity of bladder carcinoma cells. J. Urol. 154：601-605.
Radi, R., Beckman, J.S., Bush, K.M. and Freeman, B.A. (1991)：Peroxynitrite-induced membrane lipid peroxidation：the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288：481-487.
Radomski, M.W., Palmer, R.M.J. and Moncada, S. (1990)：An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87：5193-5197.
Rees, D.D, Palmer, R.M. and Moncada, S. (1989)：Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86：3375-3378.
Sano, H., Hirai, M., Satto, H., Nakashima, I. and Isobe, K.I. (1997)：A nitric oxide-releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of superoxide dismutase mRNA in the murine macrophage cell line RAW 264.7. Immuno. 92：118-122.
Saunder, J.W. (1966)：Death in embryonic system. Science 154：604-612.
Salblina, A.A., Iiyinskaya, G.V., Rubtsova, S.N., Agapova, L.S., Chumakov, P.M. (1998): Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J. Cell Sci. 111:977-984.
Shau, J.Y. and Lin, R.H. (1999)：Studies on cytogenotoxicities of nitric oxide donors and endotoxin in RAW 264.7 macrophages. (Master thesis, Institute of Medicine, Chung Shan Medical and Dental College)
Shiao, Y.H., Lee, S.H., and Kasprzak, K.S. (1998)：Cell cycle arrest, apoptosis and p53 expression in nickel (II) acetate-treated Chinese hamster ovary cells. Carcinogen. 19：1203-1207.
Simizu, S., Takada, M., Umezawa, K. and Imoto, M. (1998)：Requirement of casepase-3 (-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer. J. Bio. Chem. 273：26900-06907.
Siu, W.T., Yam, C.H. and Poon, R.Y.C. (1999)：G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells. FEBS. Leet. 461：299-305.
Smith, P., Rhodes, N.P., Shortland, A.P., Fraser, A.P., Djamgoz, M.B., Ke, Y. and Foster, C.E., (1998)：Sodium channel protein expression enhances the invasiveness of rat an human prostate cancer cells. FEBS Lett. 423：19-24.
Stopper, H., Moller, M., Bommel, H.M. and Schmidt, H.H. (1999)：Cytotoxic versus gentoxic effects of nitric oxide (NO). Toxicol. Lett. 106：59-67.
Stuehr, D.J. and Marletta, M.A. (1985)：Mammalian nitrate biosynthesis：mouse macrophages produce nitrite and nitrate in response to E. coli LPS. Proc. Natl. Acad. Sci. U.S.A. 82：7738-7742.
Tamatani, M., Ogawa, S., Niitsu, Y. and Tohyama, M. (1998)：Involvement of bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J. Neurochem. 71：1588-1596.
Tayeh, M.A. and Marletta, M.A. (1989)：Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate：tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264：19654-19658.
Teng, K.K., Esposito, D.K., Schwartz, G.D., Lander, H.M. and Hempstead, B.L. (1999)：J. Biochem. 274：37315-37320.
Toshiyuki, N., Hong, Z., Nobuhiro, M.,En L., Jin, X., Bruce, A.Y. and Junying, Y. (2000)：Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-b. Nature 403：98-103.
Ullrich, T., Oberle, S., Abate, A. and Schroder (1997)：Photoactivation of the nitric oxide donor SIN-1. FEBS Lett. 406：66-68.
Van Ark-Otte, J., Samelis, G., Rubio, G., Lopez-Saez, J.B., Pinedo, H.M. and Giaccone, G. (1998)：Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multirdug resistance phenotypes. Oncol. Rep. 5：249-255.
Wang,H., and Keiser, J.A. (1998): Molecular characterization of rabbit CPP32 and its function in vascular smooth muscle cell apoptosis. Am. J. Physiol. 274: H1132 — H1140.
Wei, T., Chen, C., Hou, J., Zhao, B., Xin, W. and Mori, A. (1999)：The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells. Toxicol. 134：117-126.
Wright, C.D., Mulsch, A., Busse, R. and Oswald, H. (1989)：Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Co. 160：813-819.
Yamamoto, K.I. and Kikuchi, Y. (1980): A comparison of diameters of micronuclei induced by clastogens and by spindle poisons. Mutat. Res. 71:127-131.
Yermilov, V., Rubio, J., Becchi, M., Friesen, M.D., Pignatelli, B. and Ohshima, H. (1995)：Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 16：2045-2050.
Zhang, J., Dawson, V.L., Dawson, T.M. and Snyder, S.H. (1994)：Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263：687-689.